PIMA542259
Envafolimab Recombinant Human Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA542259-Each-of-1 | In Stock | ₹ 44,020.62 |
PIMA542259 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,020.62
GST (18%): ₹ 7,923.712
Total Price: ₹ 51,944.332
Antigen
Envafolimab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
KN-035
Immunogen
Human CD274/PD-L1/B7-H1
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Applications
ELISA, SDS-Page
Concentration
0.5 mg/mL
Formulation
PBS with no preservative; pH 7.4
Host Species
Human
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Target Molecule
Chemical
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Envafolimab (KN035) is the world's first new fusion protein of humanized anti-PD-L1 single domain antibody and human IgG1 Fc
- Compared with the PD-1/PD-L1 antibodies currently on the market and under development, it has a distinct advantage
- Envafolimab has the advantages of subcutaneous injection, stability at room temperature, and fast tumor penetration, which can improve the compliance of tumor patients and improve the quality of life of patients, which is in line with the future trend of long-term management of tumors as chronic diseases.
Compare Similar Items
Show Difference
Antigen: Envafolimab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: KN-035
Immunogen: Human CD274/PD-L1/B7-H1
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Applications: ELISA, SDS-Page
Concentration: 0.5 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Target Molecule: Chemical
Antigen:
Envafolimab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
KN-035
Immunogen:
Human CD274/PD-L1/B7-H1
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Applications:
ELISA, SDS-Page
Concentration:
0.5 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Target Molecule:
Chemical
Antigen: Amivantamab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: JNJ-61186372; JNJ-6372; ME
Immunogen: Human EGFR/ME/RCCP2
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Applications: ELISA, SDS-Page
Concentration: 1.69 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Target Molecule: Chemical
Antigen:
Amivantamab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
JNJ-61186372; JNJ-6372; ME
Immunogen:
Human EGFR/ME/RCCP2
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Applications:
ELISA, SDS-Page
Concentration:
1.69 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Target Molecule:
Chemical
Antigen: Avizakimab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: BOS161721
Immunogen: Human IL21
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Applications: ELISA, SDS-Page
Concentration: 1.0 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Target Molecule: Chemical
Antigen:
Avizakimab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
BOS161721
Immunogen:
Human IL21
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Applications:
ELISA, SDS-Page
Concentration:
1.0 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Target Molecule:
Chemical
Antigen: Batoclimab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: HL161
Immunogen: Human FCGRT
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Applications: ELISA, SDS-Page
Concentration: 3.46 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Target Molecule: Chemical
Antigen:
Batoclimab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
HL161
Immunogen:
Human FCGRT
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Applications:
ELISA, SDS-Page
Concentration:
3.46 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Target Molecule:
Chemical